UK Veterans Desperate for Breakthrough in PTSD Treatment as Former General Calls for MDMA Therapy to be Eased
A former head of the British military is urging the government to ease restrictions on a party drug commonly associated with recreational use, calling for it to be tested more cheaply as a potential treatment for veterans struggling with post-traumatic stress disorder (PTSD).
Sir Nick Carter, who served as chief of the defence staff until 2021, believes that existing regulations are inflating the cost of trials, which could be disastrous for those affected. A single gram of "medical grade" MDMA currently costs around £10,000, compared to a street price of about £40.
The former general's plea comes after a study published in Nature Medicine found that 71% of participants who underwent MDMA-assisted therapy showed complete elimination of PTSD symptoms. This initial result has sparked hope among veterans like Martin Wade, a former lawyer with the British army, who developed complex PTSD after being deployed in Afghanistan in 2006-07.
Wade's experiences are chilling. He recalls deciding whether military operations were within UK and international law as the only lawyer on deployment, but found himself feeling increasingly responsible for what was happening on the ground. He also had to deal with a traumatic incident involving a soldier firing a warning shot into a car carrying civilians, resulting in three deaths.
Wade's struggles with PTSD led him to be abruptly discharged from the military and undergo further psychiatric treatment in hospitals. However, he has since found some relief through art therapy.
The charity Supporting Wounded Veterans, which Carter is patron of, aims to raise £2m to fund a further trial of MDMA-assisted therapy at the University of Cambridge. So far, they have raised £700,000. Wade hopes that this treatment could provide him with a new lease on life and help others like him.
By easing restrictions on MDMA, the government could unlock a potentially game-changing treatment for those affected by PTSD. With current therapies failing many veterans, Carter's call is a desperate bid to find a solution that could change lives.
"It gives you a sense of self-love when you're talking about difficult and ingrained experiences," Wade said of MDMA-assisted therapy. "Despite many years of conventional therapies... I've never been able to successfully eliminate hyper-vigilance, hyper-arousal, and flashbacks."
Wade's words echo the frustration felt by many veterans who have struggled with PTSD for years. He believes that if the government were to provide each veteran struggling with PTSD £80,000 worth of therapy, it could make a significant difference.
The government must act quickly to address this growing crisis. With Sir Nick Carter's plea echoing through the corridors of power, there is hope that a breakthrough in treatment may finally be within reach for those affected by PTSD.
A former head of the British military is urging the government to ease restrictions on a party drug commonly associated with recreational use, calling for it to be tested more cheaply as a potential treatment for veterans struggling with post-traumatic stress disorder (PTSD).
Sir Nick Carter, who served as chief of the defence staff until 2021, believes that existing regulations are inflating the cost of trials, which could be disastrous for those affected. A single gram of "medical grade" MDMA currently costs around £10,000, compared to a street price of about £40.
The former general's plea comes after a study published in Nature Medicine found that 71% of participants who underwent MDMA-assisted therapy showed complete elimination of PTSD symptoms. This initial result has sparked hope among veterans like Martin Wade, a former lawyer with the British army, who developed complex PTSD after being deployed in Afghanistan in 2006-07.
Wade's experiences are chilling. He recalls deciding whether military operations were within UK and international law as the only lawyer on deployment, but found himself feeling increasingly responsible for what was happening on the ground. He also had to deal with a traumatic incident involving a soldier firing a warning shot into a car carrying civilians, resulting in three deaths.
Wade's struggles with PTSD led him to be abruptly discharged from the military and undergo further psychiatric treatment in hospitals. However, he has since found some relief through art therapy.
The charity Supporting Wounded Veterans, which Carter is patron of, aims to raise £2m to fund a further trial of MDMA-assisted therapy at the University of Cambridge. So far, they have raised £700,000. Wade hopes that this treatment could provide him with a new lease on life and help others like him.
By easing restrictions on MDMA, the government could unlock a potentially game-changing treatment for those affected by PTSD. With current therapies failing many veterans, Carter's call is a desperate bid to find a solution that could change lives.
"It gives you a sense of self-love when you're talking about difficult and ingrained experiences," Wade said of MDMA-assisted therapy. "Despite many years of conventional therapies... I've never been able to successfully eliminate hyper-vigilance, hyper-arousal, and flashbacks."
Wade's words echo the frustration felt by many veterans who have struggled with PTSD for years. He believes that if the government were to provide each veteran struggling with PTSD £80,000 worth of therapy, it could make a significant difference.
The government must act quickly to address this growing crisis. With Sir Nick Carter's plea echoing through the corridors of power, there is hope that a breakthrough in treatment may finally be within reach for those affected by PTSD.